Evidence indicates that IL-1β maturation via the NLRP3 inflammasome pathway correlates with the progression of inflammation and fibrosis in NASH [8], and patients with this disease show increased activation of this pathway [37,38,39]. This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatohepatitis.